Wiley announced a new collaboration with Amazon Web Services (AWS) to launch a generative AI agent for scientific literature search on AWS. The first of its kind from a publisher on AWS, the AI agent was unveiled at the 7th annual AWS Life Sciences Symposium in New York City on 6 May 2025. The AI agent demonstrated how researchers can conduct comprehensive full-text scientific literature search across Wiley’s extensive journal content, moving beyond traditional abstract-only searches to access detailed content within main sections like methods and results.
The new Wiley literature search agent is available as part of an open source toolkit for healthcare and life sciences agents that has been assembled by AWS. The toolkit offers a catalog of starter agents and an orchestration framework for organizations to build and customize their agentic systems, supporting use cases from biomarker discovery to clinical trial protocol generation. The new AI agent currently includes AI searchable access to articles under the creative commons license, such as Cancer Medicine, delivering reliable and cited insights in minutes rather than the current hours- to days-long manual process of discovering and perusing dozens of articles for relevant information.
Wiley’s development of this AI agent demonstrates the company’s commitment to building innovative AI solutions while maintaining responsible AI practices through established core principles focusing on the importance of human oversight, transparency, attribution, fairness, and appropriate governance.
Read the full press release here.